Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2510 of 6351
-
Can your genes predict blood thinner effectiveness?
Knowledge-focused CompletedThis study builds, in part, upon preliminary results generated as part of the Pharmacogenomics Anti-Platelet Intervention (PAPI) Study (NCT00799396). The purpose of this investigation is to assess the impact of genetic variation in the carboxylesterase 1 (CES1) on response to clo…
Phase 4 • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
New hope for fabry patients: Long-Term drug safety confirmed
Disease control CompletedThis is a long-term, Open-label Study to Evaluate the Safety, Pharmacodynamics, and Efficacy of Migalastat in Subjects \> 12 Years of Age With Fabry Disease and Amenable GLA Variants
Phase 3 • Sponsor: Amicus Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New monthly injection aims to tame acromegaly safely
Disease control CompletedThe purpose of this trial is to assess the long-term safety and efficacy of CAM2029 in patients with acromegaly. Patients will be administered CAM2029 subcutaneously once monthly during 12 months. Patients fulfilling trial NCT04076462 will be offered to continue with open-label t…
Phase 3 • Sponsor: Camurus AB • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New metabolomic test could spot rare metabolic diseases faster
Diagnosis CompletedResearchers are trying to determine the efficacy of a global metabolomic approach in testing for and diagnosing inborn errors of metabolism as opposed to traditional testing methods.
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
Scientists track rare glycosylation disorders to unlock disease secrets
Knowledge-focused Recruiting nowThe purpose of this research is to study the natural history of congenital disorders of glycosylation and its causes and treatments.
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Can a tailored diet unlock better metabolic health?
Knowledge-focused OngoingThe purposes of this study are: 1) to determine the mechanisms responsible for the development of cardiometabolic complications in some, but not all people with obesity; 2) determine the best dietary approach for cardiometabolic health; and 3) understand why some people have a st…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Biosimilar breast cancer drug tested in everyday clinics
Disease control OngoingZedora registration was based on studies of women with metastatic breast cancer, but its approval includes adjuvant treatment. Thus, prospective data of drug use in localized disease are lacking, as well as are real-world safety and efficacy data, taking into consideration comorb…
Sponsor: Libbs Farmacêutica LTDA • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Booster vaccine for meningitis shows promise in seniors
Vaccine CompletedPrimary Objective: To demonstrate sufficiency of the vaccine seroresponse to meningococcal serogroups A, C, W, and Y following administration of a single dose of Meningococcal Polysaccharide (Serogroups A, C, Y, and W 135) Tetanus Toxoid (MenACYW) Conjugate vaccine to Group 1 pa…
Phase 3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jun 26, 2026 16:20 UTC
-
New combo therapy targets rare blood cancer in early trial
Disease control OngoingBackground: Hairy cell leukemia (HCL) is a rare, slow-growing blood cancer in which the bone marrow makes too many of certain white blood cells. The antibody Rituximab/Ruxience binds to a protein in cancerous white blood cells and is often used to treat HCL. Researchers want to …
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Heart drug vyndaqel tracked in Real-World study
Disease control CompletedSecondary Data Collection : To confirm the safety and effectiveness profiles under the actual medical practice of Vyndaqel in Japan. This study is conducted in accordance with the protocol even when Vynmac is used, and information the use of Vynmac during the observation period i…
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Promising combo for tough blood cancer hits snag, study stopped early
Disease control Stopped earlyThis phase I/II trial studies the side effects and best dose of venetoclax when given together with azacitidine in treating patients with high-risk myelodysplastic syndrome that has come back (recurrent) or does not respond to treatment (refractory). Drugs used in chemotherapy, s…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Robot-Assisted ear surgery could improve hearing implants
Disease control CompletedCochlear Implantation is a system developed to restore hearing in people with profound sensorineural hearing loss, whose classical hearing aids are ineffective. Surgery is necessary to insert the internal part into the cochlea and requires milling the mastoid to access the round …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Jun 26, 2026 19:17 UTC
-
Could a nasal swab curb unnecessary antibiotic use?
Disease control CompletedTo evaluate the impact of MRSA nasal screen implementation on duration of therapy and cost associated with vancomycin use.
Sponsor: Methodist Health System • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Couples therapy for heart patients? new program aims to heal hearts together
Symptom relief CompletedThe purpose of this study is to test the efficacy of the 8-week Healing Hearts Together (HHT) program to improve relationship quality, mental health, quality of life (QoL), and cardiovascular health. This is a randomized controlled trial in which couples are randomly assigned to …
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Can testosterone fix fragile bones in diabetic men?
Disease control CompletedLow testosterone and diabetes mellitus are each associated with increased risk for fractures. Men with diabetes mellitus are commonly found to have low testosterone as well. Testosterone has been shown to improve the bone health of patients with low testosterone but has not been …
Phase 4 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Surgery or pills? new study tackles diverticulitis dilemma
Symptom relief OngoingThe COSMID (Comparison of Surgery and Medicine on the Impact of Diverticulitis) trial is a pragmatic, patient-level randomized superiority trial of elective colectomy vs. best medical management for patients with quality of life (QoL) limiting diverticular disease. A parallel obs…
Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Can a sprinkle of powder and a wash stop joint infections?
Disease control CompletedThis is a prospective, randomized, controlled, open label, parallel four-arm design, multi-center study to compare different intraoperative interventions in the prevention of acute PJI development.
Phase 1 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Prostate cancer radiation showdown: SBRT vs. brachytherapy
Symptom relief Recruiting nowThe goal of this clinical trial is to compare SBRT (Stereotactic Body RadioTherapy) to LDRB (Low-Dose Rate Brachytherapy with Iodine-125 seed implant) in patients with low and favourable intermediate-risk prostate cancer. The two main questions it aims to answer are : 1. Does SB…
Sponsor: CHU de Quebec-Universite Laval • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Immune cells take on sarcoma in early trial
Disease control CompletedThis is a single-arm trial that will evaluate the safety and feasibility of the Tumor-infiltrating lymphocyte (TIL) treatment and the persistence of TIL survival in vivo following treatment
Phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New eye drops could ease pain and swelling after cataract surgery
Symptom relief CompletedThe DX-216 trial is a randomized, double-masked, placebo (vehicle)-controlled study evaluating the efficacy and safety of two doses of OCS-01 compared to vehicle in the treatment of inflammation and pain following cataract surgery. The primary objective is to evaluate the efficac…
Phase 2 • Sponsor: Oculis • Aim: Symptom relief
Last updated Jun 26, 2026 16:04 UTC